Abbott must pay $95 million in premature infant formula trial

ST LOUIS: A jury on Friday found that Abbott Laboratories’ specialised formula for premature infants caused an Illinois girl to develop a dangerous bowel disease, ordering the healthcare company to pay $95 million in compensatory damages.

Read more: Nigeria fines Meta $220 million over data violations

The verdict in St Louis, Missouri state court comes in the first trial against the company out of hundreds of similar claims over the formula pending in courts around the country, which Reuters viewed via Courtroom View Network.

The jury will now consider whether to award the girl’s mother punitive damages.